Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 1

Conditions

Myelodysplastic Syndromes 57Leukemia, Myeloid, Acute 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33Myeloproliferative Disorders 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Lymphoma, Non-Hodgkin 21Leukemia, Myelomonocytic, Chronic 16Hodgkin Disease 14Primary Myelofibrosis 13Polycythemia Vera 12Leukemia 11Neuroblastoma 9Multiple Myeloma 9Histiocytosis, Langerhans-Cell 9Glioma 9Wilms Tumor 8Sarcoma 8Rhabdoid Tumor 8Neuroectodermal Tumors, Primitive, Peripheral 8Medulloblastoma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hepatoblastoma 8Ependymoma 8Blast Crisis 8Anemia, Refractory, with Excess of Blasts 8Rhabdomyosarcoma 7Osteosarcoma 7Myelodysplastic-Myeloproliferative Diseases 7Leukemia, Biphenotypic, Acute 7Hematologic Neoplasms 7

Interventions

Razoxane 1Idarubicin 1Gemtuzumab 1Dexrazoxane 1Cytarabine 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Myeloid × Myeloid × 30 days × Clear all
NCT03589729 2026-05-22

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
MyeloidOther hematologic neoplasmSarcoma

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡